|
Svechnikova E.V., Zhufina S.E.
Prevalence of chronic kidney disease in patients with psoriasis: place of genetic engineering biological therapy
|
№5 / 2024
|
|
Evdokimov E.Yu., Svechnikova E.V., Ponezheva Zh.B.
The role of psoriasis in systemic inflammation in HIV-infected patients and the importance of biological therapy
|
№5 / 2024
|
|
Shulepov V.V., Novikov Yu.A., Pravdina O.V.
Review of innovative methods of therapy for psoriasis
|
№5 / 2024
|
|
Vereshchagin E.I., Svechnikova E.V., Maksimova Yu.V., Arutyunyan G.B., Artemyeva N.O., Devyatova A.V.
Hyperuricemia as a marker of chronic systemic inflammation in the pathogenesis of psoriasis
|
№5 / 2024
|
|
A.A. Martynov, A.V. Vlasova, O.S. Mishina, G.V. Lukyanova
Social characteristics of russian patients with psoriasis and arthropathic psoriasis
|
№13 / 2023
|
|
Sh.Kh.R. Sarsur, N.S. Rudneva
Results of comparison of the effectiveness of adalimumab and ixekizumab in the treatment of psoriasis
|
№13 / 2023
|
|
N.O. Pereverzina, L.S. Kruglova
Personalized approach to the treatment of patients with skin psoriasis and inflammatory back pain, taking into account comorbid pathology
|
№13 / 2023
|
|
S.F. Alyavi, A.B. Rakhmatov
Importance of the nitric oxide system in the development of psoriasis
|
№8 / 2023
|
|
I.S. Vladimirova
Psoriasis, metabolic syndrome and COVID-19: a case report
|
№14 / 2022
|
|
N.O. Pereverzina, L.S. Kruglova, T.V. Korotaeva, A.M. Lila
Systematic review and meta-analysis: predictors of psoriatic arthritis
|
№14 / 2022
|
|
E.Yu. Evdokimov, Zh.B. Ponezheva, E.V. Svechnikova, B.M. Gruzdev, A.D. Meshkov, V.S. Pykhtina
The role of systemic inflammation in HIV-infected patients with moderate and severe psoriasis
|
№10 / 2022
|
|
E.V. Svechnikova, S.E. Zhufina
Clinical case: chronic skin fold candidiasis against the background of treatment with an interleukin-17A inhibitor in a patient with extensive severe psoriasis
|
№8 / 2022
|
Русский
